Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF285CP (Zinc finger protein 285C, pseudogene) is annotated as a pseudogene in the human genome. Pseudogenes are genomic DNA sequences similar to known genes but are typically nonfunctional due to mutations or truncations and do not produce active proteins. ZNF285CP has several previous identifiers but is not a protein-coding gene, does not serve a biological role as a protein, and is not recognized as a drug target or biomarker[1][6]. ZNF285CP is a pseudogene; it is not a receptor, enzyme, transporter, or transcription factor, and it does not encode any protein product. It is not a valid target for therapeutic, diagnostic, or biomarker development. It should not be listed as a canonical drug target or receptor.
not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 285C, pseudogene (ZNF285CP).